Overview

Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Placebo in Participants With Dry Eye Disease.

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure efficacy and safety with SHJ002 sterile ophthalmic solution compared to placebo in participants with Dry Eye Disease (DED).
Phase:
Phase 2
Details
Lead Sponsor:
Dreamhawk Vision Biotech, Inc.